Home » Topics » Regulatory

Regulatory
RSS

Health Canada approves expanded label for ProstaScint

March 20, 2002

No Comments

FDA approval for new formulation of Visicol

March 18, 2002

No Comments

Risperdal approved for delaying schizophrenia relapse in U.S.

March 15, 2002

No Comments

Extended-release Zerit has similar virological activity to immediate-release drug

March 15, 2002

No Comments

CPMP recommends approval of irbesartan in diabetic renal disease

March 13, 2002

No Comments

CPMP recommends approval of Avonex in early-stage MS

March 11, 2002

No Comments

CPMP recommends expansion of desloratadine indication to indoor and outdoor allergies

March 8, 2002

No Comments

AstraZeneca submits sNDA for Arimidex in early breast cancer

March 6, 2002

No Comments

Connetics' sNDA for Olux accepted by FDA

March 5, 2002

No Comments

FDA approves Remicade for improvement of physical function in RA

March 5, 2002

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Health Canada approves expanded label for ProstaScint

FDA approval for new formulation of Visicol

Risperdal approved for delaying schizophrenia relapse in U.S.

Extended-release Zerit has similar virological activity to immediate-release drug

CPMP recommends approval of irbesartan in diabetic renal disease

CPMP recommends approval of Avonex in early-stage MS

CPMP recommends expansion of desloratadine indication to indoor and outdoor allergies

AstraZeneca submits sNDA for Arimidex in early breast cancer

Connetics' sNDA for Olux accepted by FDA

FDA approves Remicade for improvement of physical function in RA

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Probing bidirectional cancer-autoimmune link can yield new targets

Regulatory RSS

Regulatory
RSS